<code id='1841B31311'></code><style id='1841B31311'></style>
    • <acronym id='1841B31311'></acronym>
      <center id='1841B31311'><center id='1841B31311'><tfoot id='1841B31311'></tfoot></center><abbr id='1841B31311'><dir id='1841B31311'><tfoot id='1841B31311'></tfoot><noframes id='1841B31311'>

    • <optgroup id='1841B31311'><strike id='1841B31311'><sup id='1841B31311'></sup></strike><code id='1841B31311'></code></optgroup>
        1. <b id='1841B31311'><label id='1841B31311'><select id='1841B31311'><dt id='1841B31311'><span id='1841B31311'></span></dt></select></label></b><u id='1841B31311'></u>
          <i id='1841B31311'><strike id='1841B31311'><tt id='1841B31311'><pre id='1841B31311'></pre></tt></strike></i>

          focus

          focus

          author:explore    Page View:678
          Senate health committee Chair Bernie Sanders
          Sen. Berne Sanders (I-Vt.) Kevin Dietsch/Getty Images

          WASHINGTON — Sen. Bernie Sanders (I-Vt.) has a new corporate target: the food industry.

          Sanders held a hearing today on diabetes that implicated both the food and drug industries in what the American Diabetes Association estimates is a $413 billion annual cost to the health care system. That’s up 27% over the past six years, he said, and he warned that new weight loss drugs could send health care spending to the stratosphere.

          advertisement

          But the food industry received more attention, especially from Sanders, than the drugmakers and drug middlemen.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more
          Readout LOUD podcast: Live from the 2023 STAT Summit
          Readout LOUD podcast: Live from the 2023 STAT Summit

          STATWhatifCRISPRisn’tallthatcommercial?HowdoestheNurOwnstoryend?Andhowdoyoupronounce“Bayer”?Wecovera

          read more
          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more

          Eli Lilly reports tirzepatide MASH success during Q4 earnings

          DarronCummings/APTheblockbusterweightlossanddiabetesdrugsoldbyEliLillyalsoappearstoimprovefattyliver